🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate the safety (acute effects associated with i...
Status
Completed
Location
City of Hope
Start Date
2009-01
Trial ID
NCT00768287
Treatments Being Tested
This is a multicentre, randomized, active-control, pragmatic, Phase 2 pilot...
Status
Unknown
Location
Sunnybrook Health Science Centre
Start Date
2019-09-24
Trial ID
NCT04114643
Treatments Being Tested
An Open-Label, Non-Randomized, uncontrolled, single-dose pilot study of VGB...
Status
Unknown
Location
Blood diseases hospital
Start Date
2021-12-28
Trial ID
NCT05152732
Treatments Being Tested
Out of fear of bleeding, liver cirrhosis patients are often treated prophyl...
Status
Recruiting
Location
General Hospital of the Medical University of Vienna
Start Date
2023-01-19
Trial ID
NCT05667805
Treatments Being Tested
A study to learn about the long-term safety and efficacy of giroctocogene f...
Status
Recruiting
Location
The Regents of the University of California||UC Davis Health
Start Date
2022-12-28
Trial ID
NCT05568719
Treatments Being Tested
This will be the first prospective randomized controlled clinical trial dir...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2016-08
Trial ID
NCT02557672
Treatments Being Tested
The primary purpose of this study is to assess the long-term safety and eff...
Status
Enrolling By Invitation
Location
10-15 Phoenix Childrens Hospital
Start Date
2023-08-30
Trial ID
NCT05962398
Treatments Being Tested
The objective of this study is to assess whether prophylactic therapy with ...
Status
Completed
Location
Tulane University School of Medicine
Start Date
2003-06
Trial ID
NCT00221195
Treatments Being Tested
This is a phase 3, multicenter, randomized, open-label, parallel-group, con...
Status
Recruiting
Location
UCLA Health - Ronald Reagan Medical Center
Start Date
2025-09-15
Trial ID
NCT07094087
Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-1...
Status
Recruiting
Location
The University of Oklahoma Health
Start Date
2025-01-07
Trial ID
NCT06429332